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Astrocytes are the predominant glial type in the central nervous system and play
important roles in assisting neuronal function and network activity. Astrocytes exhibit
complex signaling systems that are essential for their normal function and the
homeostasis of the neural network. Altered signaling in astrocytes is closely associated
with neurological and psychiatric diseases, suggesting tremendous therapeutic potential
of these cells. To further understand astrocyte function in health and disease, it is
important to study astrocytic signaling in vivo. In this review, we discuss molecular
tools that enable the selective manipulation of astrocytic signaling, including the tools
to selectively activate and inactivate astrocyte signaling in vivo. Lastly, we highlight a few
tools in development that present strong potential for advancing our understanding of
the role of astrocytes in physiology, behavior, and pathology.
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Introduction
G protein coupled receptors (GPCRs) are the primary molecules through which non-excitable
cells transduce information from external cues to biological responses. There are four major
families of GPCRs that are distinguished by their composition, ability to activate intracellular
signaling cascades, and the functional consequences associated with their activation. The impor-
tance of GPCRs is underscored by the fact that these molecules are the most common tar-
geted class of proteins of therapeutic agents. Astrocytes express each of the major classes of
GPCRs (Porter and McCarthy, 1997) clearly demonstrating that these cells are dynamically cou-
pled to the activity of their surrounding cellular and chemical milieu. It is likely that astro-
cyte GPCRs are activated by neurotransmitters released from neurons synaptically as well as
through volume transmission. It is also likely that neighboring non-neuronal cells including
microglia, vascular endothelial cells, astrocytes, and other resident CNS cells release molecules
that activate astrocyte GPCRs and modulate astrocyte activity. In certain situations, low lev-
els of ambient neurotransmitters might tonically activate astrocyte GPCRs. However, it is likely
that in most cases astrocyte GPCRs are spatially restricted to discrete signaling domains that
are activated with different temporal characteristics dependent on the source of the signal and
biological response being affected. Layered onto this signaling complexity is the morpholog-
ical complexity of astrocytes; the fine processes of an individual astrocyte within the CA1
region of the hippocampus can associate with ∼100,000 synapses (Bushong et al., 2002). This
being the case, different regions of an individual astrocyte are likely responding simultaneously
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to local signals (from neurons or other cell types) with different
functional outcomes. Collectively, this information underscores
how difficult it is to replicate in vitro or in situ the complicated
pattern of GPCR activation that normally occurs in vivo.
By far, the emphasis in astrocyte GPCR signaling activity has
been on the regulation of Ca2+. This is not surprising given
that Ca2+ fluxes play a very important role in regulating bio-
logical processes and Ca2+ is the only signaling molecule that
we can readily monitor selectively in astrocytes in complex tis-
sue such as brain. Consequently, we know a lot about astrocyte
Ca2+ responses following the activation of Gq-GPCRs and the
consequences of increasing astrocyte Ca2+ by a number of differ-
ent approaches. Two important points need to be kept in mind
when considering findings in this area. First, most investigations
linking increases in astrocyte Ca2+ with functional responses use
pharmacological methods to increase astrocyte Ca2+ and con-
sequently findings may not reflect physiological responses. Sec-
ond, while the field has focused on the role of astrocyte Ca2+ in
functional responses, the activation of Gq-coupled GPCRs leads
to the modulation of a broad set of signaling cascades beyond
changes in Ca2+; the variety of effector proteins in Gαq “interac-
tome” may affect astrocyte Ca2+ responses as well as play impor-
tant roles in physiological responses to Gq-GPCR activation
(Figure 1; Sanchez-Fernandez et al., 2014).
Molecular Tools for Selective Activation of
Astrocytes In Vivo
Temporal Control of Astrocyte Activation In Vivo
Using Optogenetics
Optogenetics is an extremely powerful tool for activating and
inactivating neuronal circuits in vivo with high temporal resolu-
tion. Optogenetic regulation of neuronal activity generally occurs
through the flux of ions that either depolarize or hyperpolar-
ize neurons with high temporal and spatial resolution (Schoe-
nenberger et al., 2011; Lin, 2012). More recently, a number of
investigators have used this technology to activate astrocyte sig-
naling in situ and in vivo (Gourine et al., 2010; Perea et al., 2014;
Yamashita et al., 2014). It is important to understand that while
optogenetic activation of astrocytes can lead to changes in ion
fluxes across plasma and intracellular compartment membranes,
these fluxes do not remotely reflect the changes in signaling that
occur following the activation of astrocyte GPCRs, the primary
mode for activating astrocyte signaling (Agulhon et al., 2012;
Sanchez-Fernandez et al., 2014).
Multiple variants of channelrhodopsin (ChR2) have been
expressed in astrocytes, primarily to elicit Ca2+ responses
(Table 1). In vivo, activation of the ChR2 variant ChR2 (H134R)
(Nagel et al., 2005) in astrocytes in the ventral surface of the
medulla oblongata was shown to lead to increases in intracellu-
lar Ca2+ and alteration in respiratory activity of rats (Gourine
et al., 2010). This same variant of ChR2 was employed to illus-
trate the ability of astrocyte Ca2+ elevations to alter the firing
and orientation responses of mouse primary visual cortex exci-
tatory and inhibitory neurons in vivo (Perea et al., 2014). Most
recently, Beppu et al. (2014) created mice expressing the ChR
variant ChR2 (C128S) or an optogenetic proton pump (ArchT).
Activation of these optogenetic tools lead to, respectively, acidi-
fication or alkalization of astrocytes which modulated glutamate
release and ischemic damage in vivo. The remainder of studies
using ChR2 or its variants have been performed using culture or
slice preparations, but provide valuable insights into the mecha-
nisms of their ability to activate astrocytes signaling (Figueiredo
et al., 2014). A second variant, CatCh (Ca2+ translocating ChR,
which has improved Ca2+ permeability) (Kleinlogel et al., 2011)
when expressed in cultured astrocytes, was found to also increase
Ca2+ but with varying reliability compared to ChR2 (H134R) (Li
et al., 2012; Figueiredo et al., 2014). A non-ChR2 light activated
channel, the light-gated Ca2+-permeable ionotropic GluR6 gluta-
mate receptor (LiGluR), has also been used in cultured astrocytes,
with again varying results (Li et al., 2012).
The advantages of using optogenetics to activate astrocytes
are the ability to temporally and spatially control the extent of
activation. However, there are a number of important caveats
involved in the use of optogenetics to activate astrocyte signal-
ing cascades. First, it is unresolved as to the source of Ca2+
when using these optogenetic actuators in astrocytes. Extracel-
lular Ca2+ entry through ChR2 variants seems the most logical
mechanism, but a recent comparative study found that intracel-
lular stores are the primary source (Figueiredo et al., 2014). These
finding are at odds with studies from other laboratories (Li et al.,
2012), and previous research from the same authors (Gourine
et al., 2010). Current evidence indicates that both external and
internal Ca2+ sources are involved in the ChR2 induced Ca2+
signal. Second, ChR2 and its variants are non-selective cation
channels, allowing the entry of Na+ K+, H+, and Ca2+ upon
activation (Nagel et al., 2003). ChR2 expressed in the cultured
astroglia cell line GL261 display significant influx of Na+ and
Ca2+ across the cell membrane based upon fluorescent indicator
imaging (Ono et al., 2014). Additionally, significant alterations
in intracellular pH were also observed in the same study, which
has been corroborated in the recent study by Beppu et al. (2014).
Interestingly, the ChR2 (H134R) used in the two current in vivo
studies of astrocyte function was engineered to increase its ability
to depolarize cultured HEK293 and neuronal cells over wild type
ChR2 (Nagel et al., 2005; Beppu et al., 2014). Astrocytes process
intracellular changes in Na+, Ca2+, and protons in different ways
that may affect several different astrocyte functions. For example,
increases in intracellular sodium and membrane depolarization,
which is known to occur with ChR2-stimulation (Gourine et al.,
2010), could alter glutamate reuptake efficacy (Djukic et al., 2007;
Unichenko et al., 2012; Verkhratsky et al., 2013). Alterations to
intracellular pH in astrocytes are important in the regulation of
ischemic damage in vivo (Benesova et al., 2009; Beppu et al.,
2014) and gap junction connectivity (Duffy et al., 2004). It is not
unreasonable to hypothesize that ChR2 activation leads to mem-
brane depolarization of astrocytes and interferes with a number
of transport systems, most importantly glutamate, which may
lead to effects on neuronal activity. In addition, to use optoge-
netics in vivo it is necessary to use a viral vector to deliver the
optogenetic construct and may require the insertion of a light
probe to activate the optogenetic channel in deeper brain regions.
It seems very likely that these insults will lead to pathological
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FIGURE 1 | A fabric of signaling cascades can be activated by
astrocyte Gq-GPCRs. Upon Gq-GPCR activation, Gαq subunits are
known to interact with G protein-coupled receptor kinases (GRKs),
β-arrestins, Rho family of guanine exchange factors (RhoGEFs) and
phospholipase C (PLC) in astrocytes or astroglia. In addition, Gβγ
subunits are able to regulate ion channel properties, as well as to
interact with signaling molecules including cdc42, PAK-PIXα,
phospholipase A (PLA), PLC, and Ras/MAPK/ERK1/2. Many of the key
signaling molecules regulated by Gβγ are expressed in astrocytes or
astroglia. Therefore, Gq-GPCR activation in astrocytes is likely to
activate an entire fabric of downstream signaling pathways that may
include (1) GRKs-mediated glutamate transporter (GLAST) localization
(Nijboer et al., 2013), gene transcription (Atkinson et al., 2009),
metabotropic glutamate receptor 5 (mGluR5) expression (Sorensen and
Conn, 2003), and astrocytoma growth (Woerner et al., 2012); (2)
β-arrestin-mediated gene silencing (McLennan et al., 2008; Miyatake
et al., 2009; Zhu and Reiser, 2014); (3) RhoGEFs-mediated activation of
Kinectin (Santama et al., 2004), citron kinase (Ackman et al., 2007),
phospholipase D (PLD) (Burkhardt et al., 2014), diacylglycerol kinase
(DGKa) (Kefas et al., 2013), Rhophilin2 (Vedrenne and Hauri, 2006;
Danussi et al., 2013), Rock (Holtje et al., 2005; Lau et al., 2011), and
mDia1 (Shinohara et al., 2012); (4) PLC regulation of PtdIns(3,4,5)P3
(PIP3)/protein kinase B (PKB or Akt) pathway (DiNuzzo et al., 2013;
Kong et al., 2013), PtdIns(4,5)P2(PIP2)/diacylglycerol (DAG)/protein kinase
C (PKC) pathway, and PIP2/Ins(1,4,5)P3(IP3) pathway. Moreover, PKC
activation in astrocytes (Wang et al., 2002) engages PLD (Servitja et al.,
2003), c-src tyrosine kinase (CSK) (Jo et al., 2014), glycogen synthase
kinase (GSK) (Sanchez et al., 2003), and cAMP signaling. Many of
these signaling pathways are known to trigger cellular responses that
are important for astrocyte function including gene transcription and cell
migration. Box 1. Selected PIP2-induced signaling pathways in which
key molecules are expressed by astrocytes. These signaling molecules
include: Epithelial sodium channel (ENaC) (Miller and Loewy, 2013),
PLA2 (Ha et al., 2014), Myristoylated alanine-rich C-kinase substrate
(MARCKS) (Vitkovic et al., 2005), Wiskott–Aldrich syndrome protein
(WASP) (Murk et al., 2013), profilin (Molotkov et al., 2013), vinculin, talin,
and paxillin (Kalman and Szabo, 2001), ERM protein family (Persson
et al., 2010), α1-syntrophin (Masaki et al., 2010), ankyrin (Lee et al.,
2012), adipocyte protein 2 (AP2) (Rossello et al., 2012), and clathirin
(Pascual-Lucas et al., 2014).
changes that alter astrocyte responses. Overall, while optogenetic
tools are great tools to activate or silence neurons, using opto-
genetics to increase astrocyte Ca2+ bypasses the majority of sig-
naling pathways that are activated by GPCRs, as well as result
in aberrant ion fluxes that likely never occur under physiological
conditions (Fiacco et al., 2007; Agulhon et al., 2012; Wang et al.,
2013).
Selective Activation of Astrocyte Gq-GPCR
Signaling with MrgA-1
The first experimental system that enabled the specific activa-
tion of endogenous astrocyte signaling cascades in complex tissue
was the Mas-related gene A1 (MrgA-1) transgenic mouse line
(Fiacco et al., 2007) (Table 1). MrgA-1 is a Gq-GPCR that is
normally expressed in a subsets of nociceptive sensory neurons
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TABLE 1 | Tools for selectively activation of astrocyte signaling in vivo.
Class Tools Molecule Application method Comments Selected references
O
p
to
g
e
n
e
tic
s
Photo-activated cation
channel, ChR2 variant
ChR2
(H134R)
Lenti-viral vectors Localized, high temporal control of glial
activation, yet bring in non-physiological
sources of Ca2+ and significantly alter
intracellular pH; Non-selective to all cations;
Require viral injections and light-source
Gourine et al., 2010;
Figueiredo et al., 2014;
Perea et al., 2014
ChR2
(L132C);
CatCh
AAV vector Improved Ca2+ permeability compared to
ChR2 (H134R) with varying reliability; Tested
in cultured astroglia and no in vivo data
Figueiredo et al., 2014;
Li et al., 2012
ChR2
(C128S)
tetO-ChR2(C128S)-EYFP
β-actin locus knockin mice
(crossed to Mlc1-tTA mice)
Does not require virus injection but requires
light activation. Highly sensitive to light
activation. Provide high temporal control of
glial acidification
Tanaka et al., 2012,
2010; Beppu et al.,
2014
Photo-activated outward
proton pump
Archaerhodopsin
(ArchT)
tetO-ArchT-EGFP β-actin
locus knockin mice (crossed
to Mlc1-tTA mice)
Does not require virus injection but requires
light activation; High temporal control; Only
available tool for glial alkalization
Tanaka et al., 2010;
Tsunematsu et al., 2013;
Beppu et al., 2014
Photo-activated
Ca2+-permeable iGluR6
LiGluR Lipofectamine 2000
transfection
Varying reliability; Tested in cultured astroglia
and no in vivo data
Li et al., 2012
P
h
a
rm
a
c
o
g
e
n
e
tic
s
Endogenous Gq GPCR
expressed outside of the
brain
MrgA-1 tetO-MrgA-1 transgenic
mouse line (crossing to
GFAP-tTA*)
Stable expression in brain astrocytes;
Peptide ligands do not cross BBB, therefore
requires brain infusion, injection or
implantation for in vivo activation;
Low temporal control; Potential
over-activation
Fiacco et al., 2007;
Agulhon et al., 2010;
Cao et al., 2013
Engineered Gq GPCR Gq-DREADD
(hM3Dq)
GFAP-hM3Dq transgenic
mouse line**; AAV-GFAP***
Stable expression in brain astrocytes; ligand
crosses BBB and bio-inert; Long-lasting
physiological and behavioral phenotypes;
Also expressed in PNS GFAP+ glial cells and
certain non-neural cells;
Low temporal control; Potential
over-activation
Armbruster et al., 2007;
Agulhon et al., 2013;
Bonder and McCarthy,
2014
Engineered Gi GPCR Gi-DREADD
(hM4Di)
Transgenic mouse line Under characterization Armbruster et al., 2007
Engineered Gs GPCR Gs-DREADD Transgenic mouse line;
AAV-GFAP***
Under characterization Guettier et al., 2009
*Mouse line available in the Jackson Laboratory, stock No. 005964; **For various DREADD constructs and transgenic mouse lines currently available, see http://pdspit3.mml.
unc.edu/projects/dreadd/wiki/WikiStart; ***AAV-GFAP minimal promotor available via UNC Vector core.
(Dong et al., 2001) but not in the brain. The ligand used to acti-
vate MrgA-1, the peptide FMRF, does not activate endogenous
brain Gq-GPCRs (Fiacco et al., 2007). To achieve cell speci-
ficity in the brain, MrgA-1 expression was controlled by using
a tetracycline-controlled inducible expression system (tetO sys-
tem), which requires a second transgene, the transcription trans-
activator (tTA). By crossing tetO-MrgA-1 transgenic mouse to
GFAP-tTA transgenic mouse, GFAP+ glia become the only cells
in the brain that express both tTA and tetO-MrgA-1, therefore the
only CNS cells to express MrgA-1 receptor (Fiacco et al., 2007).
As a native GPCR, MrgA-1 activation triggers the entire fabric
of signaling cascades normally activated by endogenous astro-
cyte Gq-GPCRs; an important component that is absent when
selectively increasing specific signaling molecules such as IP3
and Ca2+. With respect to Ca2+, MrgA-1 activation leads to a
similar spatial and temporal response as endogenous Gq-GPCRs
in hippocampal astrocytes (Fiacco et al., 2007).
MrgA-1 transgenic mice were used to prepare brain slices to
test the gliotransmission hypothesis at hippocampal CA3-CA1
synapses (Fiacco et al., 2007; Agulhon et al., 2010; Wang et al.,
2012, 2013; Devaraju et al., 2013). Initial reports showed that
bath application of FMRFa induced widespread Ca2+ elevations
in stratum radiatum astrocytes from MrgA-1 mice, while CA1
neuronal Ca2+ activity, excitatory synaptic transmission and
short- or long-term excitatory synaptic plasticity in CA3-CA1
synapses were not affected (Fiacco et al., 2007; Agulhon et al.,
2010). Later Wang et al. reported that although MrgA-1 medi-
ated astrocyte activation did not change neuronal excitability and
miniature excitatory synaptic currents (mEPSCs) in neurons near
the surface of hippocampal slices, both bath and microinjection
of FMRFa led to a transient hyperpolarization and decreased
mEPSC frequency in neurons below 80µm depth in the slices
(Wang et al., 2012, 2013). These studies suggested that selective
activation of Gq-GPCR signaling in astrocytes increased activity
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of the Na+/K+ ATPase, resulting in a reduction of extracellular
K+ which consequently hyperpolarized neurons and suppressed
excitatory transmission (Wang et al., 2012). The Gq-GPCR acti-
vated change in [K+] was hard to detect in the superficial layer of
the slices, where the constant bath perfusion buffered the effects
(Wang et al., 2012). The K+ removal hypothesis was supported
by an independent study from Devaraju et al. who found that
both Schaffer Collaterals stimulation and selective stimulation
of astrocytic MrgA-1s potentiated inward K+ current and glu-
tamate uptake in hippocampal astrocytes (Devaraju et al., 2013).
These data suggest that astrocytic Gq-GPCR activationmay regu-
late neuronal excitability andmodulate neuronal network activity
indirectly rather than inducing the release of gliotransmitters.
The MrgA-1 mouse line is rarely used for studying astro-
cyte function in vivo because the peptide agonists do not effec-
tively cross blood brain barrier. Recently, Cao et al. used MrgA-1
mouse line to study the role of astrocytic activation in behavior
by implanting infusion cannula or osmotic pumps into the brain
of MrgA-1 mouse (Cao et al., 2013). Brain infusion of the pep-
tide agonist of MrgA-1 mice induced antidepressant-like effect
in forced swimming test and reversed depression-like behavior
in MrgA-1 mice suggesting that astrocytic Gq-GPCR signaling
is capable of modulating depressive-like behaviors (Cao et al.,
2013).
Pharmacogenetic Activation of Astrocytic
Signaling In Vivo Using DREADDs
In 2007, a new family of engineered GPCRs, Designer Recep-
tor Exclusively Activated by Designer Drugs (DREADD) were
developed (Armbruster et al., 2007) and have become the best
option for activating GPCR signaling in specific cell popula-
tions in vivo (Rogan and Roth, 2011) (Table 1). A significant
advantage of DREADDs compared to MrgA-1 is that the ligand
of DREADDs, clozapine N-oxide (CNO), crosses BBB (Bender
et al., 1994), therefore enabling non-invasive manipulation of
receptor activity via peripheral injections (e.g., intraperitoneal or
intravenous injections) and even via drinking water (Jain et al.,
2013). The M3 muscarinic cholinergic receptor (M3AChR) was
engineered through directed molecular evolution (Dong et al.,
2010) that led to a striking decrease the affinity of this receptor
for its native agonist (acetylcholine) as well as to a large increase
in affinity for CNO. In addition, DREADDs do not exhibit consti-
tutive activity and CNO is pharmacologically inert in the absence
of DREADDs (Armbruster et al., 2007; Nichols and Roth, 2009;
Dong et al., 2010). Consequently, mice expressing DREADDs do
not exhibit a phenotype in the absence of CNO and CNO does
not lead to a phenotype in wild type mice (Alexander et al., 2009;
Guettier et al., 2009; Agulhon et al., 2013). Since their devel-
opment, DREADDs have been extensively used to chronically
and acutely activate (Gq-DREADDs) and silence (Gi-DREADDs)
specific subsets of neurons in vivo (Wess et al., 2013).
Gq-DREADD was introduced into astrocyte research stud-
ies with the development of GFAP-Gq-DREADD mice for
specifically activating GFAP+ glial Gq-GPCR signaling in vivo
(Agulhon et al., 2013). Gq-DREADD expression was regu-
lated by the 2.2 Kb human GFAP promotor fragment; a
hemagglutinin (HA) tag was added to the N-terminus of the
Gq-DREADD for highly specific antibody staining. Extensive
immunostaining studies demonstrated that the expression of
Gq-DREADD was restricted to GFAP+ glia in the CNS and
PNS (Agulhon et al., 2013). Bath application of CNO in situ
or i.p. injection of CNO in vivo led to Ca2+ increases in brain
astrocytes, without affecting Ca2+ in nearby neurons; CNO
induced Ca2+ increases occurred throughout astrocytes includ-
ing their fine processes within the neuropil. The development
of this model enabled, for the first time, examination of the
behavioral and physiological consequences of specifically acti-
vating Gq-GPCR signaling in GFAP+ glia. CNO administra-
tion to GFAP-Gq-DREADD transgenic mice revealed robust
and unexpected behavioral and physiological phenotypes that
were absent in litter mate controls; phenotypic changes include
robust increases in heart rate and blood pressure, saliva for-
mation, a decrease in body temperature, and increased seda-
tion in the presence of a GABA receptor agonist (Agulhon
et al., 2013). These findings suggest that GFAP+ glia have the
potential for modulating a number of important physiological
processes.
In addition to GFAP-Gq-DREADD mice, transgenic mouse
lines expressing Gs- and Gi-DREADD specifically in GFAP+ glia
were developed and are currently under characterization in the
McCarthy laboratory. GFAP-DREADD transgenic mice offer the
best system to non-invasively and simultaneously activate widely
distributed astrocyte populations. Other systems for manipu-
lating astrocytic activity in vivo, including MrgA-1 transgenic
mice and optogenetics, requires direct application of ligand/light
to brain tissue and thus have spatial limitations with regard to
cells being activated at a given time. Region-specific expression
DREADD can be achieved via viral delivery (Bull et al., 2014).
Once the expression pattern is established, one can activate a
subset of astrocytes acutely or chronically in dose-dependent
manner, and behavior and physiological outcome can be mea-
sured from free-moving, awake mice. For the first time in astro-
cyte research, we can now test the contribution of astrocytes
GPCR signaling in physiology and behavior, as well as verify the
previously known astrocytic function in intact animals.
There are caveats associated with using pharmacogenetic sys-
tems to study the role of astrocyte Gq-GPCR signaling in vivo.
First, engineered GPCRs are driven by an exogenous promoter
system and consequently the levels of expression are likely to be
different than that of endogenous astrocytic GPCRs. While this
does not appear to lead to markedly different Ca2+ responses
compared to endogenous receptors, it has not been confirmed
that the engineered GPCR signaling cascades are regulated in
a similar manner. Second, it is impossible to mimic the tem-
poral and spatial characteristics of in vivo GPCR activation, a
caveat associated with all pharmacological stimulation. Follow-
ing an i.p. injection of CNO, most of the physiological pheno-
types were observed in 5min and peak in 30 ∼ 45min (Agulhon
et al., 2013). Increased temporal and spatial resolution can be
obtained by either microinjecting CNO into the region of interest
or uncaging CNO with laser pulse activation; the latter approach
has temporal and spatial resolution similar to optogenetic activa-
tion; caged CNO has recently been prepared (Brian Roth, per-
sonal communication). Overall, DREADD technology enables
activation of the entire fabric of endogenous signaling cascades
in specific cell types that are generally stimulated by GPCRs; this
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is a striking advantage over most other methods used to activate
glial signaling in situ or in vivo.
Selective Astrocyte Gene Rescue in Mice with
Global Gene Deletion
The optogenetic and pharmacogenetic approaches for acti-
vating astrocyte in vivo share a common pitfall of poten-
tial over-activation. Recently, a conditional endogenous gene
repair approach was used to isolate the role of astrocyte-
specific endogenous signaling in vivo in a mouse model of Rett’s
syndrome (RTT).
RTT is an X-chromosome-linked autism spectrum disor-
der due to the loss of function of the transcriptional regula-
tor methyl-CpG-binding protein 2 (MeCP2) in the brain (Amir
et al., 1999; Guy et al., 2007). Because MeCP2 is expressed in
all CNS cell types (Ballas et al., 2009), a conditional knock-in
mice, MeCP2loxp mice, was developed to study cell-specific dis-
ease mechanisms. In this model, the endogenous Mecp2 gene
is silenced by insertion of a loxP-Stop cassette, but can be acti-
vated when combined with Cre- or Cre-ER system (Guy et al.,
2007). When MeCP2loxp mice were crossed to hGFAP-CreERT2
mice (Hirrlinger et al., 2006), the expression of MeCP2 was selec-
tively restored in GFAP+ astrocytes when mice were treated
with tamoxifen (Lioy et al., 2011). The specific re-expression of
MeCP2 in astrocytes significantly improved RTT phenotype pos-
sibly by restoring normal dendritic morphology and levels of the
excitatory glutamate transporter VGLUT1 (Lioy et al., 2011). This
model illustrates the potential of using conditional astrocyte-
specific rescue model to isolate the function of astrocyte signaling
in vivo and in disease.
Spatial Control of Astrocytic Signaling via Viral
Delivery—Advantages and Disadvantages
At this time, there are no astrocyte transcriptional units that can
be used to target specific populations of astrocytes in mature
brain. Consequently, a large number of investigators have used
viral vectors to perturb signaling in subpopulations of astrocytes
using both adeno-associated viruses (AAV) and lentiviral vectors
(Figueiredo et al., 2014). Several AAV serotypes show tropism
toward astrocytes, including AAV 2/5 and AAV 8 (Koerber et al.,
2009; Aschauer et al., 2013; Petrosyan et al., 2014). In combi-
nation with an astrocytic selective promoter (Lee et al., 2008;
Pfrieger and Slezak, 2012), these AAVs are expected to express
the gene of interest selectively in astrocytes in specific brain
regions.
The disadvantages of using viral vectors to express genes in
astrocytes should not be overlooked. The most obvious concerns
are tissue damage and reactive gliosis induced by viral injection.
Reactive astrocytes display more robust, frequent and widely-
spread intracellular Ca2+ activity, and intercellular coupling and
Ca2+ waves are exaggerated among reactive astrocytes (Agulhon
et al., 2012). A recent study showed that AAV 2/5 vector can be
used to induce astrogliosis and disrupt the glutamate-glutamine
cycle in astrocytes, which led to glutamate-reversible hyperac-
tivity of nearby neurons (Ortinski et al., 2010). The primary
methods for assessing whether or not astrocytes are pathologi-
cally transformed by viral infection are through morphological
studies and GFAP expression levels (Xie et al., 2010; Shigetomi
et al., 2013a). However, it is likely that more subtle undetected
changes in astrocytes occur that could influence their functional
interactions with surrounding cells.
Another challenge of using viral injection to express con-
structs in astrocytes is cell-specificity. AAVs show tropism to all
cell types in the CNS (Aschauer et al., 2013; Gholizadeh et al.,
2013; Petrosyan et al., 2014; Yang et al., 2014). Even with an
astrocytic-specific promoter, it is important to carefully verify
astrocyte specific transduction using the most sensitive meth-
ods available. A low level of GPCR expression in non-astrocyte
cell types could lead to significant downstream signaling and
confound the interpretation of findings.
One final consideration to keep in mind is that it is cur-
rently impossible to transduce functionally distinct populations
of astrocytes in a manner analogous to transducing a subpopu-
lation of functionally distinct neurons; this will only be solved
as new subpopulation specific astrocyte transcriptional units are
identified.
Current Knock-Out Models for Selective
Inactivation of Astrocytic Signaling
Specific GPCR Knockout Models
To date, most investigators have used optogenetic, pharmaco-
genetic or pharmacological tools to determine the consequences
of activating astrocyte signaling cascades (Agulhon et al., 2008).
None of these approaches recapitulate the complex regulation of
signaling cascades occurring in vivo. Findings from these stud-
ies (see review by Agulhon et al., 2008) provide insight into the
potential outcome(s) of astrocyte signaling. However, one has
to keep in mind that these highly artificial types of stimulation
may lead to outcomes that rarely, or perhaps never, occur in
physiology. To determine the functional significance of astrocytic
signaling, a more powerful approach is to demonstrate that the
loss-of-function of a particular pathway affects physiological pro-
cesses such as synaptic transmission or behavior. Here we review
current knockout (KO) and conditional KO (cKO) models for
deleting specific astrocytic signaling pathways (Table 2).
GFAP-CB1R-KO
One of the first GPCRs targeted for a cKO in astrocytes was
the cannabinoid type-1 receptor (CB1R), a GPCR predominately
coupled to Gi signaling (Han et al., 2012). GFAP-CB1R cKO
mouse line was accomplished by crossing floxed CB1R mouse
line with an inducible Cre system driven by the GFAP promoter
(GFAP-CreERT2) (Hirrlinger et al., 2006). Following tamoxifen
administration, CB1R expression was reduced in GFAP+ astro-
cytes in the brain, providing the first model to study the con-
tribution of astrocytes in cannabinoid induced working memory
impairment in vivo. Han et al. found that conditional knockout
of astrocytic CB1R abolished cannabinoid-induced impairment
of spatial working memory and in vivo long-term depression at
hippocampal CA3-CA1 synapses. In contrast, a cKO of CB1R in
glutamatergic or GABAergic neurons did not rescue cannabinoid
induced deficit (Han et al., 2012). This study revealed significant
impact of a single astrocyte GPCR signaling system on synaptic
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TABLE 2 | Current molecular tools for perturbing astrocyte signaling in vivo.
Class Mouse line Confirmed expression
profile
In vivo phenotype Comments Selected
references
G
P
C
R
K
O
Floxed CB1R mouse
line (crossed to
GFAP-CreERT2)
79% reduction in the
number of CB1R+ CA1
astrocytes by
immunohistochemistry
Cannabinoid-induced
impairment of spatial working
memory and in vivo long-term
depression at hippocampal
CA3-CA1 synapses were
abolished
For GFAP-CreERT2 please see
Hirrlinger et al., 2006
Marsicano et al.,
2003
Floxed DrD2 mouse
line (crossed to
hGFAP-Cre)
No marked excision
detected in striatal tissue by
qPCR analysis
Mild increase in pro-inflammatory
mediators in the striatum was
detected by qPCR; Neuronal
development, neuronal numbers
and astrogliosis in advanced age
appear normal in the substantia
nigra (SNC) and the ventral
tegmental area (VTA)
Compared to global DrD2 KO,
the pro-inflammatory
phenotypes of astrocytes in the
SNC and in the striatum are very
mild. Further characterization in
other brain regions needed
Shao et al., 2013
(created by
Shanghai Research
Center for Model
Organisms)
P
e
rt
u
rb
in
g
C
a
2
+
si
g
n
a
lin
g
Global IP3R2 KO Global knockout Loss of astrocyte GPCR
mediated Ca2+ increase;
conflicting evidence for
alterations in synaptic
transmission; minor behavioral
alterations; no evidence for
altered vascular control;
alterations in astrocyte
processes mobility in response
to LTP-inducing sensory stimuli
There are two sources for the
global IP3R2 KO: Ju Chen lab at
UCSD (used by McCarthy lab)
and Katsuhiko Mikoshiba lab at
RIKEN Brain Science Institute.
There has been no direct
comparison of these two lines for
differences
Petravicz et al.,
2008; Agulhon et al.,
2010; Navarrete
et al., 2012; Bonder
and McCarthy, 2014
Floxed IP3R2
(crossed to hGFAP-Cre)
Conditional knockout, with
80–95% reduction in the
number of IP3R2+
astrocytes in brain by
immuno-histochemistry and
Gq GPCR agonist-evoked
Ca2+ imaging
Loss of astrocyte GPCR
mediated Ca2+ increases; no
reported behavioral phenotypes;
reduced cholinergic modulation
of visual responses
For hGFAP-Cre, please see
Casper and McCarthy, 2006
Chen et al., 2012;
Petravicz et al.,
2014
AAV2/5-
gfaABC1D-p130PH
Reduced ATP-evoked Ca2+
signaling in vitro and in vivo
No effect on spontaneous Ca2+
increase
Xie et al., 2010
tetO-GST-“IP3 sponge”
transgenic mice
(crossed to GLT-1-tTA
mice)
80–90% S100β+ cells are
lacZ+ in many brain regions
including CA1; Each
astrocyte on average
express 3800 “IP3 sponge”
molecules
Reduced spontaneous and
GPCR evoked Ca2+ responses;
reduced synaptic coverage by
astrocyte processes; impaired
glutamate uptake; impaired
spatial reference memory and
contextual fear responses
While alterations to the listed
behaviors and impaired
glutamate uptake were
observed, there we no significant
alterations to any synaptic
measures such as LTP and LTD
Tanaka et al., 2013
B
lo
c
ki
n
g
ve
si
c
u
la
r
re
le
a
se
tetO-dnSNARE
(crossed to GFAP-tTA)
Global astrocyte expression;
recently discovered cortical
neuronal expression
Changes in sleep-wake cycle,
sleep loss related cognitive
functions, cortical slow waves,
depressive-like behavior, LTP
induction threshold in
hippocampus, neuronal survival
after stroke, development of
temporal lobe epilepsy, and
baseline mechanical nociception
Recent in-depth analysis of
dnSNARE expression in large
population of neurons suggest
re-evaluation of thought-to-be
astrocyte-driven in vivo
phenotypes
Pascual et al., 2005;
Nam et al., 2012;
Fujita et al., 2014
TRE-loxP-STOP-loxP-
TeNT11-GFP (crossed
to GFAP-tTA and
GFAP-CreERt2 lines)
No direct data on the
percentage of astrocytes
expressing TeNT in different
brain regions from the
transgenic animals
Unaltered sleep patterns, only
the EEG power in low-gamma
range during wakefulness was
reduced; Unaltered basal
synaptic transmission as well as
normal short- and long-term
plasticity in hippocampus
Characterization of TeNT
expression profile is needed at
least in the region-of-interest in
future studies. The expression is
expected to be variable among
users due to differences in the
induction protocols
Lee et al., 2014
(Continued)
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TABLE 2 | Continued
Class Mouse line Confirmed expression
profile
In vivo phenotype Comments Selected
references
G
lu
ta
m
a
te
tr
a
n
sp
o
rt
e
r
K
O
Global Glt-1 KO Global knockout Reduced body weight, increased
morbidity, excitotoxic neuronal
death
Tanaka et al., 1997
Heterozygous global
knockout
Behavioral alterations in
sensorimotor function, locomotor
activity, anxiety, contextual and
cue-based fear conditioning
Kiryk et al., 2008
Floxed Glt-1
(crossed to
GLAST-CreERT2)
Conditional knockout Excessive repetitive and injurious
self-grooming, bodily tics,
increased excitatory transmission
at corticostriatal synapses
Aida et al., 2015
Global GLAST KO Global knockout Altered glutamate/glucose
uptake and sensory evoked
neuronal oscillations in olfactory
bulbs; impaired vestibular activity
in aged mice; reduced sociability,
reduced acoustic startle
response; impaired visual
discrimination; hyperactive
locomotor activity
Karlsson et al.,
2008, 2009; Martin
et al., 2012;
Schraven et al.,
2012
N
T
sy
n
th
e
si
s
e
n
zy
m
e
K
O
Nitrous oxide synthase
2 KO
Global knockout Increased NO production in vivo;
stress and anxiety-related
behavior alterations
Buskila et al., 2007;
Abu-Ghanem et al.,
2008
Serine-racemase cKO Conditional knockout;
Analyses of astrocyte
specific D-serine KO mice
show only a modest
reduction in serine
racemase activity
No alteration to hippocampal
LTP in situ; No in vivo phenotype
to date
Benneyworth et al.,
2012
Io
n
c
h
a
n
n
e
lK
O
Kir4.1 cKO Conditional knockout;
Complete loss of Kir4.1
expression from S100β+
and GLAST+ astrocytes as
well as CNP+
oligodendrocytes
throughout brain and spinal
cord
Increased morbidity, ataxia,
stress-induced seizures, brain
anatomical changes,
white-matter vacuolization;
reduced potassium buffering
in vivo
Disorganized and fragmented
processes of cerebellar Bergman
glia, spinal cord white matter
astrocytes, and motor neurons
Djukic et al., 2007;
Chever et al., 2010
C
o
n
n
e
xi
n
K
O
s
Cx30 and Cx43 KO
and cKO
Multiple global and
conditional knockout
models
Alterations to spatial working
memory, motor coordination,
sensorimotor adaptation, anxiety,
and pain perception
There exist multiple global,
conditional and combinatorial
knockouts (for example global
Cx30 KO with astrocyte specific
Cx43 knockout)
For comprehensive
reviews of connexin
genetic models,
please see reviews
by Giaume and
Theis (2010) and
Pannasch and
Rouach (2013)
modulation and behavior, as well as presented an elegant in vivo
system for temporal control of astrocytic signaling.
GFAP-DRD2-cKO
In 2013, an astrocyte dopamine D2 receptor (DRD2) condi-
tional knockout mouse was generated to study the role of astro-
cytic GPCR signaling in aging-related neuroinflammation (Shao
et al., 2013). DRD2 couples to Gi (Missale et al., 1998) and
is expressed in astrocytes in vivo (Khan et al., 2001). During
aging, DRD2 expression is downregulated in the brain (Kaasi-
nen et al., 2000), suggesting potential involvement of DRD2 in
aging related neuroinflammation. In this study DRD2-deficient
astrocytes were found to produce more proinflammatory media-
tors compared to wild-type astrocytes. Further, this effect appears
to be mediated through a decrease in αB-crystallin (CRYAB) sig-
naling, a small heat-shock protein known to negatively regulate
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pro-inflammatory mediator production and to display neuro-
protective effect (Ousman et al., 2007). Interestingly, DRD2-
deficient astrocytes also show robust GFAP upregulation, and
a reactive morphology in the substantia nigra and the striatum
of aged mice (Shao et al., 2013), suggesting the possible link
between astrocytic GPCR signaling and age-related impairments
in cognitive and motor function.
Models for Removing or Partially Removing
Astrocytic Ca2+ Fluxes In Vivo
IP3R2 Germline and Conditional IP3R2 Knockout
Astrocytic Gq-GPCR/PLC/IP3 signaling is the most intensely
studied pathway in the proposed modulation of neuronal activity
and cerebral blood flow by astrocytes and has been the subject
of numerous reviews (Haydon and Carmignoto, 2006; Agulhon
et al., 2008, 2012; Fiacco et al., 2009; Halassa and Haydon, 2010;
Hamilton and Attwell, 2010). The activation of this pathway
results in the release of Ca2+ from IP3 receptor (IP3R) regu-
lated intracellular stores in the endoplasmic reticulum. Astro-
cytes express only one of three subtypes of this receptor, IP3R
type 2 (IP3R2) (Sharp et al., 1999; Holtzclaw et al., 2002; Foskett
et al., 2007; Hertle and Yeckel, 2007). The first functional report
to confirm this was published by Petravicz et al. (2008), in which
the germline IP3R2 knockout mouse (generated by the Ju Chen
lab; Li et al., 2005) was found to lack somatic increases in intra-
cellular Ca2+ upon activation of multiple subtypes of Gq-GPCRs
known to exist on astrocytes. Further experiments using this
model have confirmed that astrocytes lack Gq-GCPR elicited,
IP3R-dependent Ca2+ signals in their processes and soma (Agul-
hon et al., 2010; Di Castro et al., 2011; Panatier et al., 2011;
Takata et al., 2011; Navarrete et al., 2012; Tamamushi et al., 2012;
Nizar et al., 2013). The IP3R2 KO mouse is fertile, displays no
overt alterations in brain development, and displays no obvious
behavioral alterations (in contrast to the IP3R1 KO, the primary
neuronal IP3R Matsumoto and Nagata, 1999). Due to these fea-
tures, this mouse model has become one the most utilized mouse
models in astrocyte research. Use of this model has led to novel
findings (Panatier et al., 2011; Navarrete et al., 2012; Haustein
et al., 2014; Perez-Alvarez et al., 2014), several of which have been
contradictory with previously held theories concerning astrocyte-
neuron communication and vascular control (Fiacco et al., 2007;
Petravicz et al., 2008; Agulhon et al., 2010; Nizar et al., 2013;
Takata et al., 2013; Bonder and McCarthy, 2014). Recently, evi-
dence of residual Ca2+ signaling of a non-IP3R origin has been
published using genetically encoded Ca2+ indicators (GECIs) in
the IP3R2 KO model (Haustein et al., 2014; Kanemaru et al.,
2014), further illustrating the model’s usefulness for discovery of
novel signaling events in astrocytes; importantly, there is no evi-
dence suggesting that this residual Ca2+ signaling is regulated by
neuronal activity.
Due to its restricted expression pattern in the CNS, a germline
knockout of IP3R2 provides a clean and reliable model to block
the release of intracellular Ca2+ in astrocytes elicited by Gq-
GPCR activity in vivo. However, this model suffers in that it lacks
tissue specificity, as do all germline knockout models. IP3R2 is
expressed in multiple tissues outside the CNS including the heart
(Li et al., 2005), pancreas (Orabi et al., 2012), lungs, liver, and
kidneys (Fujino et al., 1995); this leads to potential confounding
issues in the use of this model in vivo when assessing the role
of astrocyte GPCR-dependent Ca2+ fluxes in behavior. Addition-
ally, concerns over compensation due to the role of intracellular
Ca2+ signaling during development have been raised regarding
this model; however to date no evidence for altered development
leading to compensation has been reported.
In an attempt to address some of these issues, a conditional
IP3R2 knockout mouse model was developed by our laboratory.
This model was generated by crossing the original floxed IP3R2
mouse developed by Dr. Ju Chen at UCSF (Li et al., 2005) to a
GFAP-Cre recombinase mouse (Stehlik et al., 2006) to restrict the
deletion of IP3R2 to GFAP+ cells in the CNS. This model recom-
bines the floxed IP3R2 allele at a high rate (>80–85% GFAP+
cells lack IP3R2), significantly reducing the number of astrocytes
responding to Gq-GPCR activation or neuronal activity in mul-
tiple brain regions (Petravicz et al., 2008; Chen et al., 2012). The
use of the GFAP-Cre system spatially and temporally restricts the
IP3R2 deletion to GFAP+ glia, thereby making it more appropri-
ate for in vivo analysis such as behavioral characterization and
reduces potential developmental compensation. Our lab recently
published a behavioral analysis of the IP3R2 cKOmice and found
no significant alteration to behavior (Petravicz et al., 2014). Most
importantly, no alterations to learning and memory as assessed
by the Morris Water Maze test were observed in these mice,
despite previous literature proposing an important role for astro-
cyte IP3R-mediated Ca2+ signaling in hippocampal LTP. It is
unlikely that developmental compensation occurs such that alter-
native ions substitute for Ca2+ in physiological processes or that
global rewiring of neuronal circuits occurs to compensate for the
loss of astrocyte Ca2+ fluxes. Nevertheless, to completely rule
out developmental compensation, it will be necessary to prepare
inducible IP3R2 cKO mice using mice expressing floxed IP3R2
and an astrocyte specific inducible Cre system.
IP3 Sponges
Activation of Phospholipase C beta (PLCβ) and sequential release
of IP3 are the key steps in Gq-GPCR mediated intracellular Ca2+
elevations. Traditional approaches to abolish Gq-GPCR medi-
ated Ca2+ elevation in astrocytes include chelating intracellular
Ca2+ with BAPTA, or preventing IP3-mediated release of Ca2+
from ER using IP3R2 KO mice. Recently, the Pleckstrin Homol-
ogy domain of PLC-like protein (p130PH), which binds cytosolic
IP3 molecules, was used to suppress astrocytic Ca2+ signaling
in vitro and ATP-induced astrocytic Ca2+ responses in vivo (Xie
et al., 2010). In this study, p130PH was selectively expressed in
cortical astrocytes in vivo using rAAV2/5 vector in combination
with a specific astrocyte promoter, gfaABC(1)D (Lee et al., 2008;
Xie et al., 2010). p130PH transduced astrocytes in the somatosen-
sory cortex exhibited reduced amplitude and frequency of Ca2+
activity in response to direct ATP application on cortex com-
pared to non-transduced astrocytes, whereas the characteristics
of spontaneous Ca2+ activity in p130PH-transduced astrocytes
remained unchanged (Xie et al., 2010). Therefore, p130PH serves
as a more selective tool to suppress Gq-GPCR induced Ca2+ ele-
vations without chelating Ca2+ activity in astrocytes completely.
This system serves as a nice addition to IP3R2KO and IP3R2 cKO
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mouse lines to distinguish astrocyte functions regulated by ER
released Ca2+ vs. channel mediated Ca2+ in vivo.
The expression of a fragment of the IP3 binding domain
of IP3R1, an “IP3 sponge” (Iwasaki et al., 2002) can also be
used to suppress IP3 induced Ca2+ release in astrocytes in vivo
(Tanaka et al., 2013). These investigators found that suppres-
sion of astrocyte Ca2+ responses affected several behavioral
responses, but no underlying evidence for alterations to synaptic
transmission was found. Surprisingly, astrocytes expressing the
“IP3 sponge” exhibited process retraction surrounding synapses,
which was attributed to underlie the behavioral phenotypes.
Recently, evidence that astrocyte processes retract in response
to LTP-inducing stimuli in vivo was reported, and that this fea-
ture was lacking in IP3R2 KO mice (Perez-Alvarez et al., 2014).
These findings appear to contradict those reported by Tanaka
et al. (2013). Further comparison between these two methods of
blocking astrocyte Ca2+ increases will be required to clarify this
contradiction.
Blocking Vesicular Release from Astrocytes with
dnSNARE or Tetanus Toxin
Ca2+ dependent release of neurotransmitters from astrocytes,
termed “gliotransmission,” is one of the most important con-
cepts presented in glial biology over the past several decades
(Araque et al., 2014). While several mechanisms have been sug-
gested to underlie gliotransmission, most studies support a pro-
cess dependent on a vesicular release system (i.e., a SNARE
dependent process) similar to that found in neurons (Zorec et al.,
2012; Sahlender et al., 2014). To test the significance of SNARE-
mediated gliotransmission to synaptic function, a mouse line that
expresses a dominant negative form of SNARE (dnSNARE) in
astrocytes was developed in our laboratory in 2005 (Pascual et al.,
2005). This line was prepared by coinjecting three independent
constructs (tetO-lacZ, tetO-dnSNARE, and tetO-eGFP) into fer-
tilized zygotes. In dnSNARE transgenic mice, the expression of
the cytosolic portion of the SNARE domain of synaptobrevin 2,
lacZ, and eGFP are controlled by tetracycline regulatory system.
When crossed with GFAP-tTAmice, the expression of dnSNARE,
lacZ, and eGFP are independently controlled by doxycycline. In
the absence of doxycycline, dnSNARE is expressed and inter-
feres with SNARE-dependent vesicular release. A limitation of
this model is that since dnSNARE was not directly tagged, there
is no way in situ to verify that it is not expressed in cells other
than astrocytes. Nevertheless, the dnSNAREmice have been used
in a large number of studies to demonstrate a role for gliotrans-
mission in synaptic transmission, synaptic plasticity, as well as
behavior. However, a recent paper performed an in-depth anal-
ysis of dnSNARE mice and found that that the expression of
dnSNARE was also expressed by a large population of neurons
(Fujita et al., 2014). Given the critical role of the SNARE complex
in neurotransmitter release, these findings bring into question the
validity of this model and the findings obtained using this system.
Studies using dnSNARE mice suggest that SNARE-mediated
astrocytic release of ATP and subsequent adenosine receptor acti-
vation regulates neuronal excitability and synaptic plasticity in
many brain regions as well as modulate certain behaviors includ-
ing sleep (Nam et al., 2012). The dnSNARE mice exhibit a weak
sleep phenotype under basal conditions, as well as an atten-
uated “rebound” response to sleep deprivation (Halassa et al.,
2009). Cortical slow oscillations, a rhythm characterizing non-
rapid eye movement (non-REM) sleep was also found impaired
in dnSNARE mice (Fellin et al., 2009). Further, the hippocam-
pal dependent memory deficits produced by sleep deprivation
were rescued in dnSNAREmice (Florian et al., 2011). These stud-
ies suggest that astrocytes release ATP in vesicular manner and
that this plays an important role in sleep patterns and cortical
oscillations.
Tenanus toxins (TeNTs) are known to interfere with synap-
tic vesicular release as well as other processes dependent on
vesicular protein trafficking (Galli et al., 1994). Recently, a trans-
genic model system was developed using TeNT to block vesicular
release in astrocytes in vivo (Lee et al., 2014). This transgenic
model took advantage of both the tetracycline inducible regu-
latory system and the Cre-dependent inducible system to block
vesicular release from astrocytes. A transgenic line was prepared
that contained the tetracycline response element (TRE) followed
by a floxed stop cassette and a cassette that when expressed led
to the expression of eGFP tagged TeNT (TRE-loxP-STOP-loxP-
TeNT11-GFP). In this system, the expression of TeNT required
Cre expression to remove the floxed stop cassette and tetracycline
transactivator (tTA) to activate the TRE. TRE-loxP-STOP-loxP-
TeNT11-GFP mice were crossed with GFAP-tTA and GFAP-
CreERt2 lines to create a triple transgenicmouse line. In the triple
transgenic mice TeNT can be expressed in astrocytes following
tamoxifen treatment; the expression of TeNT is suppressed in the
presence of doxycycline. In this model, astrocyte expression of
TeNT requires that two different transgenes driven by the GFAP
promoter be expressed in the same astrocyte markedly increasing
the probability of astrocyte specific expression. Further, as TeNT
was directly tagged with eGFP, it is possible to identify all cells
expressing TeNT. In contrast to the impaired sleep pattern in
dnSNARE mice, astrocytic TeNT-expressing mice showed unal-
tered sleep patterns compared to triple transgenic mice without
tamoxifen or double transgenic mice with tamoxifin (Lee et al.,
2014). Studies using this mouse line indicate that basal synaptic
transmission as well as normal short- and long-term plasticity in
hippocampus in situ is not altered by the expression of TeNT (Lee
et al., 2014); these findings bring into question the concept that
astrocytes release gliotransmitters that modulate synaptic trans-
mission and plasticity via a vesicular dependent process. Interest-
ingly, the EEG power in low-gamma range during wakefulness
was reduced, whereas the EEG power during but not non-REM
sleep remain unchanged (Lee et al., 2014). These observations
in sleep regulation from astrocytic TeNT-expressing mice do not
match with those from dnSNARE mice.
Memory deficit was also detected in themice expressing TeNT
in astrocytes using novel object recognition test (Lee et al., 2014).
Fast local field potential oscillations in the gamma frequency
are closely correlated with many cognitive functions, including
learning, memory storage and retrieval and attention (Basar-
Eroglu et al., 1996). Astrocytic TeNT-expressing mice did not
show deficit in other behavior tests that involves simpler form of
memory processing or are less dependent on cortical processing.
The reduction of gamma oscillation power and significant deficit
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in novel object recognition suggest that the fast neural circuit
oscillations are regulated by astrocytes (Lee et al., 2014).
Mouse Models for Assessing Astrocyte
Neurotransmitter Regulation
Glutamate Transporter Knockout Mouse Models
Astrocytes are responsible for 80–90% of glutamate reuptake in
the brain (Tzingounis and Wadiche, 2007), and two of the five
glutamate transporters (GluTs) are primarily expressed in astro-
cytes: Glt-1/EAAT2 and GLAST/EAAT1 (Danbolt, 2001; Huang
and Bergles, 2004). There are currently germline knockoutmouse
models for both Glt-1 (Tanaka et al., 1997) and GLAST (Harada
et al., 1998); however their use in vivo has been limited. The Glt-
1 germline knockout mouse model suffers from reduced body
weight, increased morbidity, and progressive neuronal death due
to excitotoxocity (Tanaka et al., 1997). This limits the ability to
conduct in vivo experiments, which typically require older mice,
to examine the role of astrocytic glutamate reuptake via Glt-1.
Recently, the heterozygous Glt-1 (Glt-1 Het) knockout model
has become an attractive model for studying the role of Glt-
1 in vivo. The Glt-1 Het model does not suffer from the more
obvious adverse effects of the full Glt-1 knockout, and displays
several interesting behavioral phenotypes and has allowed for the
study of Glt-1 in several brain pathologies (Kiryk et al., 2008).
The GLAST knockout mice are viable, enabling in vivo studies.
GLAST is primarily expressed in the cerebellum and olfactory
bulb (Regan et al., 2007), and this mouse model has led to inter-
esting findings concerning the physiological (Martin et al., 2012;
Schraven et al., 2012) and pathological (Karlsson et al., 2008,
2009) functions of GLAST. Recently, a Glt-1 floxed mouse model
has been developed (Aida et al., 2015). Induced knockout of Glt-
1 in adult animals resulted in development of repetitive behav-
iors and alterations to excitatory transmission due to reduced
glutamate uptake. The floxed Glt-1 model when combined with
inducible Cre systems will open up new avenues of research into
the role of Glt-1 in vivo that were not possible due to the lethality
of the germline Glt-1 KO.
Nitrous Oxide Synthase 2 Knockout
In the central nervous system nitric oxide serves a number of
roles, and has been shown to act at glutamatergic synapses to
enhance glutamate release (Garthwaite, 2008). While neurons in
many brain regions are known to produce and release NO via
nitric oxide synthase (nNOS), this does not account fully for the
activity of NO in several brain regions where excitatory neurons
lack nNOS expression. Astrocytes are known to express all three
isoforms of NOS, and are the sole expressers of an inducible
form of NOS (iNOS or NOS2) that is activated in response to
physiological stress in a Ca2+ dependent manner (Murphy, 2000;
Buskila et al., 2005; Amitai, 2010). Astrocyte-derived NO has
been shown to enhance LTP of presynaptic afferents in the spinal
cord, as well as enhance synaptic transmission in the neocortex
in acute slice preparations (Ikeda and Murase, 2004; Buskila and
Amitai, 2010). In vivo evidence for astrocytic-derived NO being
a modulator of neuronal transmission has primarily come from
the use of a NOS2 knockout mouse, in which it was discovered
that deletion of the calmodulin-binding domain of NOS2 led to a
net increase in overall NO concentrations in the brains of mutant
mice. Interesting, the increase in NO originated from astrocytes
through an alternate mechanism without alterations in the rela-
tive levels of NOS isoforms (Buskila et al., 2007). Further, these
mice display stress and anxiety-related alterations to behavior
suggesting a role for astrocyte-derived NO in the modulation of
neural circuits (Abu-Ghanem et al., 2008). Currently, the role of
astrocyte-derived NO in modulation of neuronal circuit activity
remains an understudied area of glial research.
Astrocytic Serine-Racemase Conditional Knockout
D-serine has long been considered one of the three primary
gliotransmitters along with ATP/adenosine and glutamate, with
putative astrocyte derived D-serine reported to modulate neu-
ronal NMDA receptors (Panatier et al., 2006; Billard, 2008; Oliet
and Mothet, 2009; Martineau, 2013; Shigetomi et al., 2013b; Sild
and Van Horn, 2013). The enzyme responsible for D-serine pro-
duction (serine racemase, SR) was initially found to be primarily
expressed by astrocytes with some modest expression in neu-
rons (Schell et al., 1995; Mothet et al., 2005). However, more
recent studies have called this expression pattern into question
(Miya et al., 2008; Ding et al., 2011; Ehmsen et al., 2013). The
most recent study of SR localization in mice and human brains
finds that nearly all immunostaining for SR is found in neurons
and not astrocytes (Balu et al., 2014). Recently, cell type specific
knockouts of SR were generated to examine the relative contri-
butions of astrocytes and neurons in the forebrain of mice (Ben-
neyworth et al., 2012). The astrocyte specific knockout of SR led
to a modest (∼15%) reduction in SR expression, while the neu-
ronal knockout in forebrain neurons reduced SR by much larger
amounts (∼65%). Further, the neuronal specific SR knockout dis-
played alterations to LTP at hippocampal synapses that were not
found in the astrocyte SR knockout. These findings raise new
questions in how astrocytes may be regulating D-serine availabil-
ity in the brain, which the astrocyte specific SR knockout will be
crucial to resolving.
Knockout Models for Astrocyte Membrane
Channels
Kir4.1
One of the major roles in the CNS for astrocytes is the buffer-
ing of potassium ions in response to neuronal activity. Astrocytes
express a variety of potassium channels, but among them Kir4.1
plays a predominant role in their K+ buffering capacity (Takumi
et al., 1995; Higashi et al., 2001; Djukic et al., 2007). A germline
full Kir4.1 knockout model has provided insight into the role
of potassium buffering in response to hyperammonemic condi-
tions (Stephan et al., 2012) and the channel’s role in regulating
astrocyte membrane potential during development (Seifert et al.,
2009). An astrocyte conditional knockout model for Kir4.1 was
generated by theMcCarthy lab to provide a cleaner animal model
alternative to the germline KO (Djukic et al., 2007). The condi-
tional knockout astrocytes display reduced glutamate clearance
and decreased resting membrane voltage, while neuronal plastic-
ity was enhanced implicating Kir4.1 as an important mediator
of extracellular potassium regulation. These finding have been
confirmed in an in vivo study utilizing the Kir4.1 cKO, with the
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cKO mice found to have reduced capacity to regulate extracel-
lular potassium levels compared to controls (Chever et al., 2010).
Usage of this model in awake mice to examine the effect of altered
potassium homeostasis may provide unique insights into how
astrocytes regulate neuronal networks.
Connexins
Astrocytes in the brain exist not only as single units occupy-
ing a discrete domain, but also as a network of cells connected
by connexin (Cx) gap junctions. Astrocytes express two major
connexin proteins (Cx43 and Cx30) with germline and condi-
tional knockout mouse models existing (Dermietzel et al., 2000;
Teubner et al., 2003; Wiencken-Barger et al., 2007). These mouse
models display a variety of alterations to behavior, synaptic
transmission, metabolic support, and ion homeostasis (Giaume
and Theis, 2010; Pannasch and Rouach, 2013). However, there
are a large number of open questions concerning the role of
gap junction communication and astrocyte networks in vivo.
Currently, the only in vivo experiments in these models have
involved behavioral studies, indicating a significant impact on
neuronal circuit function (for an excellent review please see
Pannasch and Rouach, 2013). Further exploration of neuronal
activity in vivo utilizing these models, as well as generation of
inducible knockout systems, represents novel avenues of research
for understanding astrocyte network function.
Current Limitations in Genetically Targeting
Astrocytes
At this time, there is not a single gene delivery system that can be
used to exclusively express transgenes or recombine naïve genes
in astrocytes. The common astrocyte marker proteins (GFAP,
S100b, glutamine synthetase, aquaporin 4, connexin43, GLAST,
GLT1, ALDH1L1) are either expressed in alternate subsets of
mature CNS cells (Dunham et al., 1992; Zhuo et al., 2001; Su
et al., 2004; Hachem et al., 2005; Regan et al., 2007; Donato et al.,
2013), in progenitor CNS cells that give rise to multiple CNS cell
types (Hartfuss et al., 2001; Casper and McCarthy, 2006), or are
expressed outside the CNS (Jessen et al., 1990; Rinholm et al.,
2007; Darlot et al., 2008; Meabon et al., 2012; Rutkovskiy et al.,
2012; Jesus et al., 2014; Kato et al., 2014). The GFAP transcrip-
tional regulatory unit (TRU) is probably the best characterized
and most frequently used TRU for regulating gene expression in
astrocytes and serves as a good example to illustrate the difficul-
ties in targeting genes to astrocytes. The GFAP TRU is active in
progenitor cells that give rise to astrocytes, neurons, and oligo-
dendrocytes (Casper and McCarthy, 2006). Even in the mature
CNS, certain populations of neurons express GFAP (Zhuo et al.,
2001; Su et al., 2004; Regan et al., 2007). Further, in the periph-
ery, non-myelinating peripheral glia (Jessen et al., 1990) as well
as certain populations of non-neural cells (e.g., stellate cells in
the liver) are GFAP+ (Lim et al., 2008) and will express trans-
genes driven by the GFAP TRU. To avoid transgene expression
in progenitor cells, many laboratories have developed inducible
gene regulatory systems (Casper and McCarthy, 2006; Hirrlinger
et al., 2006; Mori et al., 2006). This approach circumvents gene
expression in progenitors during development but does not affect
the expression of transgenes in peripheral glia, adult stem cells or
small populations of neurons that normally express GFAP. How
much of a problem this presents depends on the question being
asked. When studying a transgene in the mature CNS that can
be assumed not to affect developmental processes nor lead to a
peripheral phenotype it is reasonable to use many of the available
astrocyte TRU to drive transgenes to astrocytes. For example, the
GFAP TRU can be used to express eGFP, GCaMP, or DREADD
receptors that must be activated by an exogenous ligand without
preventative concern about developmental expression. However,
when using the GFAP TRU to drive bioactive molecules such as
DREADD receptors or inducible Cre recombinase, it is impor-
tant to remain cognizant that in addition to astrocytes, peripheral
GFAP+ cells, adult stem cells, and certain neurons will also be
affected. Alternatively, when expressing molecules that innately
affect biological processes (e.g., a dominant negative mutation,
constitutively active signaling molecule or Cre recombinase), it
is very important to consider the consequences of expression
during development.
The above discussion assumes that the astrocyte TRU is acting
with the fidelity of the endogenous TRU. Unfortunately, this is
often not the case and is largely dependent on the genomic con-
struct used to prepare the TRU. Most typically, investigators use
a fragment of the TRU to drive transgene expression. As trans-
genes generally integrate somewhat randomly at active sites in the
genome, the activity of surrounding genomic regulatory units can
markedly affect transgene expression levels as well as the cells the
transgene is expressed. This problem is markedly reduced using a
BAC approachwhere very large genomic segments containing the
TRU and inserted transgene are used to prepare transgenic lines.
One final difficulty is that there are no astrocyte TRU systems that
can be used to target subpopulations of astrocytes. Currently, the
only way to genetically-manipulate subpopulations of astrocytes
is to transduce these cells using viral vectors. Unfortunately, this
generally restricts the size of the TRU used to target astrocytes
and requires viral injection that may lead to subtle or striking
changes in astrocyte function.
In summary, genetic manipulation of astrocytes is a very
powerful tool for assessing the role of these cells in physiology,
disease, and behavior. However, just as one has to verify the speci-
ficity of pharmacological reagents, great care must be used to
insure the specificity of genetic manipulations.
Emerging Technologies for Manipulating
Astrocytic Signaling In Vivo
Temporal Control of GPCR Signaling Using
Optogenetic GPCRs
Optogenetically activated GPCR signaling is a reasonable alter-
native to ChR2 stimulation in astrocytes. There are two sys-
tems based on adrenergic receptors: Opto-alpha-1 (Gq linked)
and opto-beta-1 (Gs linked) (Airan et al., 2009). Activation of
these systems use similar experimental methods as optogenet-
ics, but have the advantage of activating endogenous signaling
cascades that exist in astrocytes. To date, these systems have
not been tested for astrocytes in vivo, only in astroglia in cul-
ture (Figueiredo et al., 2014). While the Gq-linked opto-alpha-1
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predictably elicited Ca2+ increases via release from intracellu-
lar stores, the Gs-linked opto-beta-1 was found to also trigger
Ca2+ increases in a cyclic AMP-dependent manner. In culture
systems, it has been shown that the Gβγ subunit of Gs-coupled
GPCRs is capable of directly gating IP3Rs (Zeng et al., 2003).
Recently, experiments in HEK293 cells discovered that IP3R2
complexes with Gαs and type 6 adenyl cyclase (AC6), and facili-
tates crosstalk between the two signaling pathways (Tovey et al.,
2008, 2010). Further study into the mechanism behind increases
in Ca2+ in astrocytes may lead to the identification of novel
pathways regulating Ca2+ signaling.
Recently, the concept of using opsin based-pigments to
develop optogenetic tools for modulating GPCR signaling was
suggested (Koyanagi and Terakita, 2014). One of the candi-
dates is melanopsin (OPN4), a Gq-coupled opsin that is orig-
inally found in a subtype of retinal ganglion cells (Hatori and
Panda, 2010; Sexton et al., 2012). Several groups have used ectopic
expression of OPN4 to control intracellular Ca2+ dynamics in
neurons (Koizumi et al., 2013). In 2013, Karunarathne and col-
leagues used non-rhodopsin opsins to activate native Gq, Gi/o,
and Gs signaling in localized regions of a single cell, and were
able to gain spatial-temporal control over immune cell migra-
tion (Karunarathne et al., 2013b) as well as neurite initiation and
extension (Karunarathne et al., 2013a). These studies suggest high
potential of opsins as optogenetic GPCRs for in vivo astrocyte
research.
Studying G-Protein Independent Signaling Using
Biased DREADDs
One important aspect of GPCR signaling in astrocytes that has
rarely been explored is the role of G-protein independent sig-
naling. Endogenous GPCR activation not only initiates signaling
via heterotrimeric G proteins, but also recruits proteins of the
arrestin family, which act as scaffolding proteins and promote
G protein-independent signaling (Pierce et al., 2002; Rajagopal
et al., 2010; Shukla et al., 2011). Research has shown that arrestin
3 (β-arrestin 2) is expressed in astrocytes ex vivo (Bruchas et al.,
2006; McLennan et al., 2008), and it is involved in kappa opioid
receptor (KOR)-induced proliferation (McLennan et al., 2008;
Miyatake et al., 2009), reduction of chemical-induced apoptosis
(Zhu and Reiser, 2014), CXCR7mediated inflammatory response
(Odemis et al., 2012; Lipfert et al., 2013) and beta 2-adrenergic
receptor (β2AR)-mediated glycogenolysis (Dong et al., 2001; Du
et al., 2010) in astrocytes. As a scaffolding protein, β-arrestins also
mediate internalization and ubiquitylation for many ion chan-
nels and transporters expressed in astrocytes (Shukla et al., 2011).
As the list of signaling pathways that β-arrestins can regulate in
astrocytes grows, it is important to dissect the relative contri-
bution of G-protein independent signaling pathway to known
functions of astrocytic GPCR signaling.
Recently, a modified Gq-DREADD that has strong biases
toward arrestin-signaling was developed (Nakajima and Wess,
2012). This receptor was generated by introducing a point muta-
tion within the highly conserved DRY motif [Rq(R165L)] of
Gq-DREADD, which results in lack of ability to activate het-
erotrimetic G proteins. Therefore, CNO-induced Rq(R165L)
activation has no effect on the levels of conventional second
messages, but can promote CNO-dependent and arrestin-
dependent signaling in biological systems (Nakajima and Wess,
2012). This novel GPCR represents an excellent tool to study
the relative contribution of G protein-dependent and indepen-
dent pathways in the known function of astrocytes, as well
as reveal the physiological roles of astrocytic-arrestin signaling
in vivo.
Conditional Gαq/Gα11 KO
GPCR KO mouse lines for all the known Gα subunits have been
developed to analyze the physiological function of GPCR signal-
ing in vivo (Offermanns, 1999), many of which show deficiencies
in CNS-related physiology (Offermanns, 2001). Although these
KO mouse lines are not astrocyte specific, inducible and con-
ditional Gαq/Gα11 KO mice are available (Wettschureck et al.,
2001) and can be combined with astrocytic specific Cre mouse
line to selectively knock out Gq-GPCR signaling in astrocytes.
The conditional Gαq/Gα11 KO system was developed to
study the role of Gαq/Gα11 signaling in specific tissues with-
out developmental problems exhibited in the constitutive KO
mouse line for both genes. This mouse line was developed using
the Cre/LoxP system where the Gαq gene (gnaq) is condition-
ally inactivated in Gα11 KO (gna11–/–) mice, which do not
have obvious behavior defect (Stanislaus et al., 1998). There-
fore, mice homozygous for gnaqflox gene appear normal until
Cre recombinase is introduced. The conditional Gαq/Gα11 KO
mouse was first used with MLC2a-Cre to obtain cardiomyocyte-
specific Gαq/Gα11 deficiency, resulting in a nearly complete
recombination of gnaqflox in cardiomyocytes (Wettschureck
et al., 2001).
In 2006, the Gαq/Gα11 cKO mice was crossed to mice
that express Cre under the control of the promoter of the
Ca2+/calmodulin-dependent protein kinase IIα gene (Camkcre4
mice) to generate forebrain specific and neuronal Gαq/Gα11
double KO mice (Wettschureck et al., 2004, 2006; Broicher et al.,
2008), resulting in impaired endocannabinoid levels, increased
seizure susceptibility (Wettschureck et al., 2006), and lack of
maternal behavior in females (Wettschureck et al., 2004). The
Gαq/Gα11 cKO line was also used to disrupt glial Gq/11 signal-
ing in combination with Nestin-Cre mouse (Wettschureck et al.,
2005), resulting in loss of Gq/11 in the neural stem cells that gives
rise to both neurons and astrocytes. Although the Gq/11 signal-
ing deficiency did not cause gross morphological changes in the
developing nervous system, pups with insufficient Gq/11 signal-
ing suffers from hypothalamic growth hormone deficiency and
somatotroph hypoplasia, dwarfism, and anorexia (Wettschureck
et al., 2005). Given the availability of astrocytic-specific Cre mice,
it will be possible to isolate the contribution of astrocytic Gq/11
signaling in vivo.
Summary and Future Directions
There is no doubt that genetic tools will play an important role
in understanding the role of astrocytes in physiology, behavior,
and neurological disorders. Studies cited above provide strong
evidence that astrocytes are doing much more than simply
insulating synapses and providing nutrients to neurons. It is not
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surprising that findings using genetic tools may conflict with pre-
vious findings using pharmacological methods to perturb astro-
cyte function. It is also not surprising that different genetic
approaches (e.g., dnSNARE and tetanus toxin expression) may
yield different results. These conflicts require additional studies
using multiple tools (pharmacological and genetic) to refine our
understanding of astrocyte function. Currently, there are several
important limitations in the genetic tools available for perturb-
ing astrocyte function in vivo. First, we are extremely limited
in the transcriptional units (promoters) available for expressing
molecules in astrocytes. Currently, all available transcriptional
units drive transgene expression in cells other than astrocytes.
Further, during development, most astrocyte promoters drive
gene expression in progenitor cells that give rise to neurons,
oligodendrocytes, and astrocytes (Casper and McCarthy, 2006).
Consequently, it is necessary to use inducible systems linked to
astrocyte promoters to avoid transgene expression in progenitors
during development. Second, when expressing transgenes that
drive function, it is important to remember that the transgene
may be overexpressed and targeted to cellular compartments not
normally found. While this can be partially overcome using an
inducible gene regulatory system, it is likely that this will remain
a caveat until we know a great deal more about the cell machin-
ery in astrocytes that target molecules to specific cellular com-
partments. Third, we currently lack promoters that can be used
to drive transgene expression in subtypes of astrocytes. Subtype
specific astrocyte promoters will enable important advances with
respect to the heterogeneity of astrocytes as well as their different
functional roles.
In summary, while genetic manipulation of astrocytes is in its
early stages of development, genetic models have already pro-
vided important insight into the role of astrocytes in physiol-
ogy, behavior, and neurological diseases. It seems very likely
that future advances in this field will depend largely on
genetic approaches currently available as well as those under
development.
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